Non-Surgical Locoregional Therapies Alone or in Combination with Systemic Therapy in Patients with Hepatocellular Carcinoma
Perla Chami(American University of Beirut), Carla Hajj(Memorial Sloan Kettering Cancer Center), William R. Jarnagin(Memorial Sloan Kettering Cancer Center), Neal Kim(Memorial Sloan Kettering Cancer Center), James J. Harding(Memorial Sloan Kettering Cancer Center), Maria El Homsi(Memorial Sloan Kettering Cancer Center), Christopher H. Crane(Memorial Sloan Kettering Cancer Center), Ghassan K. Abou‐Alfa(Memorial Sloan Kettering Cancer Center), Haibo Lin(Affiliated Hospital of Shaanxi University of Chinese Medicine)
Cited by 8
Related Papers
Tumour exosome integrins determine organotropic metastasis
|Nature|2015|5.2k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
OncoKB: A Precision Oncology Knowledge Base
|JCO Precision Oncology|2017|2.7k
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma
|NEJM Evidence|2022|1.4k